Get the Stockscreener App
25.36
3.61%
-0.915
Progyny Inc stock is traded at $25.36, with a volume of 343.59K.
It is down -3.61% in the last 24 hours and down -20.67% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$26.28
Open:
$26
24h Volume:
343.59K
Relative Volume:
0.26
Market Cap:
$1.94B
Revenue:
$1.29B
Net Income/Loss:
$67.69M
P/E Ratio:
32.94
EPS:
0.7701
Net Cash Flow:
$184.42M
1W Performance:
-9.05%
1M Performance:
-20.67%
6M Performance:
+24.47%
1Y Performance:
+8.25%
1-Day Range:
$25.27
$26.13
1-Week Range:
$25.27
$28.23
52-Week Range:
$16.10
$33.06
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
25.34 | 2.02B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
394.30 | 360.59B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.20 | 124.26B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
390.58 | 86.82B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
274.91 | 74.66B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
383.72 | 46.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny (PGNY) Q2 2026 Earnings Call Transcript - aol.com
Discipline and Rules-Based Execution in PGNY Response - Stock Traders Daily
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook - marketbeat.com
Royal Bank of Canada Has $3.71 Million Stock Position in Progyny, Inc. $PGNY - marketbeat.com
The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call - Yahoo Finance
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $36 - moomoo.com
PGNY Maintains Buy Rating -- Price Target Raised to $36.00 by Tr - GuruFocus
Truist raises Progyny price target to $36 after strong Q2 results and growing institutional support - Pluang
Truist Adjusts Price Target on Progyny to $36 From $33, Maintains Buy Rating - Moomoo
Progyny Inc (PGNY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Progyny, Inc. (PGNY) Stock Forecasts - Yahoo Finance
PGNY Maintains Rating by Barclays -- Price Target Lowered to $30 - GuruFocus
Sei Investments Co. Decreases Stake in Progyny, Inc. $PGNY - marketbeat.com
Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Progyny Drops 5.4% Amid Sector-Wide Selling - AlphaStreet
Progyny, Inc. $PGNY Shares Sold by Janus Henderson Group PLC - marketbeat.com
Progyny (PGNY) Short Interest & Short Float | Updated Aug 2026 - marketbeat.com
Why Progyny (PGNY) Shares Are Sliding Today - Yahoo Finance
Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up - Yahoo Finance
Quantinno Capital Management LP Grows Position in Progyny, Inc. $PGNY - marketbeat.com
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance - Yahoo Finance
Progyny Inc (PGNY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND) - The Globe and Mail
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35 - Moomoo
Progyny (PGNY) Stock Sinks As Guidance Jitters Clash With Margin Strength - simplywall.st
PGNY SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Progyny Inc (PGNY) Stock News Today - TradingKey
Progyny Posts Record Q2 Results, Expands Client Base - The Globe and Mail
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35 - moomoo.com
Progyny, Inc. Releases Q2 2026 Form 10-Q Filing Highlighting Financials and Risks - kalkinemedia.com
Why Progyny Stock Plunged, Then Gradually Recovered Today - AOL.com
Progyny CEO to present at Canaccord Genuity Ann... - Pluang
Progyny (NASDAQ:PGNY) Shares Gap DownHere's What Happened - MarketBeat
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference - GlobeNewswire
Progyny, Inc. 2026: Revenue $350.51M, EPS $0.34— 10-Q Summary - TradingView
Progyny, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Progyny, Inc. Stock 12‑Month Price Target Cut to $33.82, Implies 12% Upside - TradingView
Progyny Q2 2026 Earnings Call Transcript - MarketBeat
Progyny, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-08-07 - Seeking Alpha
Progyny Outlook FY Adjusted Ebitda USD 233-24 - Moomoo
Progyny Inc (PGNY) (Q2 2026) Earnings Call Highlights: Record Re - GuruFocus
106,654 Shares in Progyny, Inc. $PGNY Bought by Empowered Funds LLC - marketbeat.com
Is Progyny Inc (PGNY) Fairly Valued After Q2 Earnings? EPS Matches Estimate at $0.34 with Revenue of $350.5 Million - GuruFocus
Progyny Q2 Earnings Call Highlights - marketbeat.com
Progyny Q2 2026 earnings: Margin expansion lifts profit faster than revenue - TradingKey
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Progyny (NASDAQ:PGNY) Issues FY 2026 Earnings Guidance - MarketBeat
Progyny (NASDAQ:PGNY) Issues Q3 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Progyny beats Q2 2026 estimates, shares sink after hours - Investing.com
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Progyny, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):